ResourceDrug Discovery & Development
Context-first data for trustworthy AI in biopharma
17 Aug 2026This whitepaper examines how a context-first data strategy enables scalable, regulator-ready AI across biopharmaceutical research, development, and manufacturing. Discover why embedding structure, semantics, provenance, and governance at the point of data creation improves AI explainability, regulatory credibility, and enterprise-wide adoption while supporting faster, more confident decision-making throughout the product lifecycle.
Resource details:
Resource type: Whitepaper
Page count: 6
Read time: 10 mins
Links
Tags
Artificial Intelligence / Machine LearningArtificial intelligence (AI) and machine learning (ML) are transformative technologies used to analyze complex data, identify patterns, and make data-driven predictions across diverse scientific fields. Automate the analysis of large or complex data sets using AI algorithms and leverage machine learning models to improve diagnostics, accelerate drug discovery, and refine experimental design. Discover the best AI/ML software, platforms, and analytical tools in our peer-reviewed product directory: compare features, read customer reviews, and request pricing directly from manufacturers.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.